We are live on ! Find out more
CTC

Central Trust Company Portfolio holdings

AUM $5.53B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+2.14%
1 Year Est. Return
+28.94%
3 Year Est. Return
+83.96%
5 Year Est. Return
+104.85%
10 Year Est. Return
+351.46%
AUM
$1.51B
AUM Growth
+$9.99M
Cap. Flow
-$12.7M
Cap. Flow %
-0.84%
Top 10 Hldgs %
19.92%
Holding
1,417
New
217
Increased
264
Reduced
441
Closed
109

Top Buys

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$5.65M
2
CEF icon
Sprott Physical Gold and Silver Trust
CEF
+$4.05M
3
JPM icon
JPMorgan Chase
JPM
+$1.44M
4
AMGN icon
Amgen
AMGN
+$1.41M
5
CB icon
Chubb
CB
+$1.22M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$2.97M
2
VZ icon
Verizon
VZ
+$2.06M
3
WFC icon
Wells Fargo
WFC
+$1.89M
4
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$1.76M
5
TIP icon
iShares TIPS Bond ETF
TIP
+$1.73M

Sector Composition

Rank Sector Weight
1 Miscellaneous 16.35%
2 Healthcare 12.68%
3 Industrials 12.5%
4 Technology 11.98%
5 Consumer Staples 11.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SINA
1151
DELISTED
Sina Corp
SINA
$1K ﹤0.01%
+12
New +$1.01K
AIG.WS
1152
DELISTED
American International Group, Inc.
AIG.WS
$1K ﹤0.01%
61
– –
HZNP
1153
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1K ﹤0.01%
+108
New +$1.34K
AVHI
1154
DELISTED
A V Homes, Inc.
AVHI
$1K ﹤0.01%
65
– –
QCP
1155
DELISTED
Quality Care Properties, Inc.
QCP
$1K ﹤0.01%
58
– –
KYO
1156
DELISTED
Kyocera Adr
KYO
$1K ﹤0.01%
+20
New +$1.15K
FTR
1157
DELISTED
Frontier Communications Corp.
FTR
$1K ﹤0.01%
88
+1
+1% +$23
GG
1158
DELISTED
Goldcorp Inc
GG
$1K ﹤0.01%
+100
New +$1.4K
GCVRZ
1159
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$1K ﹤0.01%
2,957
+23
+0.8% +$9
AGI icon
1160
Alamos Gold
AGI
$14.9B
$0 ﹤0.01%
+36
New +$256
AHRT
1161
AH Realty Trust
AHRT
$473M
– –
-3,546
Closed -$49K
AIV
1162
Aimco
AIV
$354M
– –
-495
Closed -$3K
ANIP icon
1163
ANI Pharmaceuticals
ANIP
$1.62B
– –
-785
Closed -$39K
APVO icon
1164
Aptevo Therapeutics
APVO
$3.39M
– –
0
– –
AVA icon
1165
Avista
AVA
$3.1B
– –
-400
Closed -$16K
DCH
1166
Dauch Corp
DCH
$1.54B
– –
-110
Closed -$2K
BDJ icon
1167
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.7B
– –
-2,955
Closed -$25K
BLDP
1168
Ballard Power Systems
BLDP
$672M
$0 ﹤0.01%
+4
New +$11
BMRN icon
1169
BioMarin Pharmaceuticals
BMRN
$12.6B
– –
-8
Closed –
BN icon
1170
Brookfield
BN
$84.6B
– –
-2,242
Closed -$29K
BPT
1171
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
– –
-40
Closed –
CALM icon
1172
Cal-Maine
CALM
$3.49B
– –
-200
Closed -$7K
CENT icon
1173
Central Garden & Pet Co
CENT
$2.48B
– –
-1,533
Closed -$45K
CHKP icon
1174
Check Point Software Technologies
CHKP
$13.3B
– –
-8
Closed –
CII icon
1175
BlackRock Enhanced Captial and Income Fund
CII
$1.05B
– –
-29
Closed –
45 46
47
48 49

Similar funds

GAM
Generali Asset Management Trieste, Italy $5.53B AUM 35.1% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $5.54B AUM 1.33% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return

Central Trust Company's Q2 2017 Portfolio in Review

As of Q2 2017, Central Trust Company held 1,417 positions worth $1.51B, up 0.66% from $1.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Central Trust Company's Q2 2017 filing shows 217 new, 264 increased, 441 reduced and 109 closed positions. Its largest new stake was Abiomed Inc: 2,855 shares worth $409K. The largest sale was Xilinx Inc, an estimated $2.97M.

By sector, the portfolio is most concentrated in Miscellaneous at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Central Trust Company's largest Q2 2017 buy was Abiomed Inc: 2,855 shares worth $409K.
  • Central Trust Company added most to iShares Gold Trust in Q2 2017, an estimated $5.65M increase.
  • Central Trust Company's biggest Q2 2017 reduction was Xilinx Inc, cutting an estimated $2.97M.
  • Central Trust Company fully exited Zayo Group Holdings, Inc. in Q2 2017, selling an estimated $91K.
  • Central Trust Company's ten largest holdings make up 20% of its $1.51B portfolio in Q2 2017.
  • Central Trust Company opened 217 new positions and closed 109 in Q2 2017.
  • Central Trust Company's portfolio value rose 0.66% quarter-over-quarter to $1.51B.

Based on Central Trust Company's 13F filing for Q2 2017, filed 14 Jul 2017.